Evaluation of Serum Amyloid A Levels in Celiac Disease

Cakmak R., EKMEN N., KAVUTÇU M., GÜLBAHAR Ö., ARHAN M.

MEDICAL JOURNAL OF BAKIRKOY, vol.17, no.3, pp.248-253, 2021 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 3
  • Publication Date: 2021
  • Doi Number: 10.4274/bmj.galenos.2021.32932
  • Journal Name: MEDICAL JOURNAL OF BAKIRKOY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.248-253
  • Keywords: Celiac disease, serum amyloid A, C-reactive protein, RHEUMATOID-ARTHRITIS, A-PROTEIN, VITAMIN-D, RISK
  • Gazi University Affiliated: Yes

Abstract

Objective: In celiac disease (CD), gluten intake triggers the release of T-cell-derived pro-inflammatory cytokines leading to an increase in the level of serum amyloid A (SAA). To confirm inflammation caused by CD in patients, SAA level is expected to be a better biomarker candidate than C-reactive protein (CRP). This study investigated the relationship between clinical and biochemical variables used in the follow-up of CD patients and SAA levels.